09:28 : Piper Jaffray gives shares of Achillion Pharmaceuticals ([[ACHN]] +4.2%) ... -
Piper Jaffray gives shares of Achillion Pharmaceuticals (ACHN +4.2%) a boost after initiating coverage with an Overweight rating. Piper may have been listening when the drugmaker's CEO told a health care conference that ...
11:42 : Achillion Pharmaceuticals Inc. (ACHN) Begins Dosing for Hepatitis C Treatme -
Achillion Pharmaceuticals Inc., focused on developing treatments for infectious disease, today announced it has begun dosing in a phase 1 clinical trial of ACH-2684 for the treatment of chronic hepatitis C virus (HCV) ...